BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11564976)

  • 1. Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta.
    Rossi MA; Colombini-Netto M
    J Hypertens; 2001 Sep; 19(9):1567-79. PubMed ID: 11564976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
    Neto-Ferreira R; Novaes Rocha V; da Silva Torres T; Mandarim-de-Lacerda CA; de Carvalho JJ
    Exp Toxicol Pathol; 2011 Jul; 63(5):473-8. PubMed ID: 20537513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition.
    Török J; Kristek F
    Vascul Pharmacol; 2002 Mar; 38(3):177-82. PubMed ID: 12402517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats.
    Medeiros MV; Binhara IM; Moreno Júnior H; Zatz R; De Nucci G; Antunes E
    Eur J Pharmacol; 1995 Oct; 285(2):109-14. PubMed ID: 8566127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats.
    de Campos Grifoni S; Bendhack LM
    Pharmacology; 2004 Mar; 70(3):160-8. PubMed ID: 14752236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
    Moreau P; Takase H; Küng CF; Lüscher TF
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
    Kameyama H; Takeda K; Kusaba T; Narumiya H; Tanda S; Kuwahara N; Yamada K; Tamagaki K; Okigaki M; Hatta T; Sasaki S
    Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats.
    Zicha J; Dobesová Z; Kunes J
    Hypertens Res; 2006 Dec; 29(12):1021-7. PubMed ID: 17378375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
    Morton JJ; Beattie EC; Speirs A; Gulliver F
    J Hypertens; 1993 Oct; 11(10):1083-8. PubMed ID: 8258672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
    López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Antihypertensive Effect of Carthamus tinctorius L. Extract and Captopril in L-NAME-Induced Hypertensive Rats via Restoration of eNOS and AT₁R Expression.
    Maneesai P; Prasarttong P; Bunbupha S; Kukongviriyapan U; Kukongviriyapan V; Tangsucharit P; Prachaney P; Pakdeechote P
    Nutrients; 2016 Feb; 8(3):122. PubMed ID: 26938552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
    Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
    Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.